课题基金 / 基金详情

Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation

Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation
PI 3-激酶亚型作为 dsRNA 传感和炎症的新型调节剂
批准号:
BB/R017972/1
负责人:
Bart Vanhaesebroeck
金额:
$56.47万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

Bart Vanhaesebroeck的其他基金

相似基金

相关文献

中文摘要
翻译
该提案旨在研究哺乳动物细胞内基本过程的重要调节因子(称为磷酸肌醇 3-激酶(或简称 PI3K))的作用。 PI3K的功能之一是将信号从细胞外部传递到细胞内部,并使细胞做出适当的反应。这个过程称为信号转导。另一个功能是重塑细胞内膜以控制称为囊泡运输的过程。信号转导和囊泡运输是相互关联的,但需要了解其工作原理。 哺乳动物细胞有八个 PI3K 家族成员,分为三个亚组。一个重要的科学问题是阐明不同 PI3K 家族成员的功能并找出它们的工作原理。 迄今为止,科学家主要研究了 I 类 PI3K,并发现了不同家族成员在健康组织以及癌症、炎症和糖尿病中的特殊功能。针对 I 组 PI3K 的药物目前正在人类癌症和过敏的临床试验中进行测试。 III 族 PI3K 已被证明对于细胞吸收的材料的分配和加工以及有助于保持细胞清洁和组织的称为自噬的过程非常重要。 目前,人们对 II 类 PI3K 知之甚少,尤其是它们在细胞中控制的过程以及它们是否可以成为有用的药物靶点。在本提案中,我们计划探索 II 组 PI3K 的新功能,并找出它们如何在细胞水平上发挥这些作用。在探索性研究中,我们发现了一个重要的信号转导过程,其中囊泡交通和 II 组 PI3K 似乎参与其中。这是通过 Toll 样受体检测所谓的病原体相关分子模式 (PAMP)。它们可以作为具有此类 PAMP 的外来入侵者(例如病毒和细菌)的探测器,对我们身体的免疫反应至关重要。这些受体也与疫苗的作用以及最近的癌症有关。其中一些发现是通过研究 PI3K 已失活的小鼠而获得的,目的是揭示这些 PI3K 在生物体中的作用以及它们如何发挥作用。 我们相信,我们提出的研究可以阐明 II 组 PI3K 控制内体运输和 Toll 样受体信号传导相互作用的机制。这可能在未来为开发可以干扰这些过程的药物提供理论基础,以最终对抗免疫系统失调的疾病,例如炎症性疾病。 这是一项基础科学提案,将增强我们对基本生物现象的了解。从长远来看,这项研究可能有助于更好地了解疾病过程并开发新药物。
英文摘要
This proposal seeks to investigate the roles of important regulators of fundamental processes inside mammalian cells, called phosphoinositide 3-kinases (or PI3Ks in short). One function of PI3Ks is to transmit signals from the outside to the inside of cells, and make the cells respond in appropriate ways. This process is called signal transduction. Another function is to remodel intracellular membranes to control a process called vesicular trafficking. Signal transduction and vesicular trafficking are interconnected, but much needs to be learned about how this works. Mammalian cells have eight family members of PI3K, divided in three subgroups. An important scientific question is to clarify the functions of the different PI3K family members and find out how they work. Thus far, scientists have mainly studied the group I PI3Ks and discovered specialised functions of the different family members, both in healthy tissue and in cancer, inflammation and diabetes. Drugs against group I PI3Ks are currently being tested in clinical trials in human cancer and allergy. The group III PI3K has been shown to be important for the distribution and processing of materials taken up by cells, as well as for a process called self-eating that helps to keep the cell clean and organized. At the moment, very little is known about the group II PI3Ks, especially about the processes they control in cells and whether they could be useful drug targets. In this proposal, we plan to explore novel functions of the group II PI3Ks, and to find out how they carry out these roles at the cellular level. In exploratory studies, we have identified an important signal transduction process in which vesicular traffic and the group II PI3K appear to be involved. This is the detection of so-called pathogen-associated molecular patterns (PAMPs) by Toll-like receptors. These serve as detectors of foreign invaders exhibiting such PAMPs, such as viruses and bacteria, and are crucial for our body's immune response. These receptors have also been implicated in how vaccines work and more recently, in cancer. Some of these discoveries have been made by studying mice in which PI3Ks have been inactivated, in order to uncover what these PI3Ks do in the living organism, and how they work. We believe that our proposed studies can clarify the mechanism by which group II PI3Ks control the interplay of endosomal traffic and the signalling by Toll-like receptors. This might, in future, provide the rationale to develop drugs that could interfere with these processes, to ultimately combat diseases where the immune system is deregulated, such as inflammatory conditions. This is a fundamental science proposal that will enhance our knowledge about basic biological phenomena. In the longer term, it is possible that this research may lead to a better understanding of disease processes and to the development of new medicines.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.devcel.2022.06.011
发表时间: 2022-07-25
期刊: Developmental cell
影响因子: 11.8
作者: [Posor Y, Kampyli C, Bilanges B, Ganguli S, Koch PA, Wallroth A, Morelli D, Jenkins M, Alliouachene S, Deltcheva E, Baum B, Haucke V, Vanhaesebroeck B]
通讯作者: Vanhaesebroeck B
DOI: 10.1042/bcj20200277
发表时间: 2020-09-30
期刊: The Biochemical journal
影响因子: --
作者: [Conduit SE, Vanhaesebroeck B]
通讯作者: Vanhaesebroeck B
DOI: 10.1038/s41573-021-00209-1
发表时间: 2021-10
期刊: Nature reviews. Drug discovery
影响因子: --
作者: []
通讯作者:
PI3K in Stemness Regulation: From Development to Cancer
PI3K 在干细胞调控中的作用:从发育到癌症
DOI: 10.20944/preprints201911.0170.v1
发表时间: 2019
期刊:
影响因子: --
作者: [Madsen R]
通讯作者: Madsen R
Integration of lipid and protein kinase signalling in primary cilia biology
  • 批准号:
    BB/W007460/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.23万
  • 财政年份:
    2022
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
  • 批准号:
    MC_PC_MR/S02607X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $7.55万
  • 财政年份:
    2019
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
  • 批准号:
    BB/M013278/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $15.7万
  • 财政年份:
    2016
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Revised Milestone 1 for Grant Reference BB/M013278/1
  • 批准号:
    BB/N013522/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $5.05万
  • 财政年份:
    2015
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
国内基金
海外基金
第452位络氨酸磷酸化PI3Kp85抗体的制备方法和使用方法
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    迟寅秀
  • 依托单位:
力学响应干细胞外囊泡通过Sclerostin/PI3K/AKT轴促进骨腱界面损伤愈合的作用机制研究
  • 批准号:
    2026JJ50337
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖汉
  • 依托单位:
NCAPD2通过PI3K-AKT-mTOR-Myc信号轴促进子宫内膜样癌增殖及EMT的机制与靶向治疗研究
  • 批准号:
    JCZRLH202600400
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于“痞积转化”理论探究网果酸模通过PI3K/Akt通路调控巨噬细胞极化平衡抑制胃癌的分子机制​